Abstract
Autism spectrum disorders (ASD) are a group of severe pervasive neurodevelopmental disorders (PDD) affecting between 1 and 3 % of pediatric populations. It is characterized by a highly variable impairment in social interaction and verbal and nonverbal communication, as well as by a stereotyped repetitive behavior, learning problems, and aloofness. ASD behavioral symptoms are frequently accompanied by immunological derangements, including cellular immune dysregulation, chronic inflammatory states, and neuroimmune alterations. Currently, the involvement of the immune pathology in autism remains unclear, and we consider that a better understanding would be useful for earlier clinical and therapeutic interventions. The main aim of this chapter is to review the most current aspects regarding the etiology of autism, with particular reference to the contribution of inflammatory events occurring in the periphery and into the brain, and how they can influence the abnormal development of the offspring and modulate the typical behaviors frequently observed in autism.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abdallah MW, Larsen N, Grove J, Norgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM (2012) Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav Immun 26(1):170–176. doi:S0889-1591(11)00521-6 [pii] 10.1016/j.bbi.2011.09.003
Abrahams VM, Schaefer TM, Fahey JV, Visintin I, Wright JA, Aldo PB, Romero R, Wira CR, Mor G (2006) Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I: C). Hum Reprod 21(9):2432–2439. doi:10.1093/humrep/del178
Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA (2011) Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol 11:22. doi:10.1186/1471-230X-11-22
Afzal N, Murch S, Thirrupathy K, Berger L, Fagbemi A, Heuschkel R (2003) Constipation with acquired megarectum in children with autism. Pediatrics 112(4):939–942
Ahern PP, Izcue A, Maloy KJ, Powrie F (2008) The interleukin-23 axis in intestinal inflammation. Immunol Rev 226:147–159. doi:IMR705 [pii] 10.1111/j.1600-065X.2008.00705.x
Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28(6):885–900
Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB (2010) Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol 20(2):83–93. doi:10.1089/cap.2009.0022
Ashwood P, Wakefield AJ (2006) Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 173(1–2):126–134. doi:S0165-5728(05)00539-4 [pii] 10.1016/j.jneuroim.2005.12.007
Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 23(6):504–517. doi:474304 [pii]
Ashwood P, Wills S, Van de Water J (2006) The immune response in autism: a new frontier for autism research. J Leukoc Biol 80(1):1–15. doi:jlb.1205707 [pii] 10.1189/jlb.1205707
Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, Pessah IN, Van de Water J (2008a) Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 204(1–2):149–153. doi:S0165-5728(08)00293-2 [pii] 10.1016/j.jneuroim.2008.07.006
Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, Pessah IN, Van de Water J (2008b) Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 204(1–2):149–153. doi:S0165-5728(08)00293-2 [pii] 10.1016/j.jneuroim.2008.07.006
Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J (2011a) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25(1):40–45. doi:S0889-1591(10)00428-9 [pii] 10.1016/j.bbi.2010.08.003
Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J (2011b) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25(1):40–45. doi:S0889-1591(10)00428-9 [pii] 10.1016/j.bbi.2010.08.003
Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET (2010) Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40(12):1423–1430. doi:10.1007/s10803-010-1006-y
Ayyoub M, Raffin C, Valmori D (2012) Generation of Th17 from human naive CD4+ T cells preferentially occurs from FOXP3+ Tregs upon costimulation via CD28 or CD5. Blood 119(20):4810–4812; author reply 4812-4813. doi:119/20/4810 [pii] 10.1182/blood-2012-02-409722
Banks WA (2012) Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology 153(9):4111–4119. doi:en.2012-1435 [pii] 10.1210/en.2012-1435
Barak Y, Kimhi R, Stein D, Gutman J, Weizman A (1999) Autistic subjects with comorbid epilepsy: a possible association with viral infections. Child Psychiatry Hum Dev 29(3):245–251
Ben-Ari Y (2002) Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 3(9):728–739
Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF (2004) Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 104(1):100–106. doi:10.1182/blood-2004-01-0107 2004-01-0107 [pii]
Bettelli E, Korn T, Kuchroo VK (2007) Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 19(6):652–657. doi:S0952-7915(07)00133-1 [pii] 10.1016/j.coi.2007.07.020
Bilbo SD, Schwarz JM (2009) Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 3:14. doi:10.3389/neuro.08.014.2009
Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML (2001) Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 31(6):537–543
Bradstreet JJ, Smith S, Granpeesheh D, El-Dahr JM, Rossignol D (2007) Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. Med Hypotheses 68(5):979–987. doi:S0306-9877(06)00753-5 [pii] 10.1016/j.mehy.2006.10.015
Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H (2010) Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125(Suppl 1):S1–18. doi:10.1542/peds.2009-1878C
Buitelaar JK, van Engeland H, van Ree JM, de Wied D (1990) Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4–9), in 14 outpatient autistic children. J Autism Dev Disord 20(4):467–478
Burgess NK, Sweeten TL, McMahon WM, Fujinami RS (2006) Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord 36(5):697–704. doi:10.1007/s10803-006-0100-7
Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C (2005) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42(4):318–321. doi:10.1136/jmg.2004.024646
Cannell JJ (2008) Autism and vitamin D. Med Hypotheses 70(4):750–759. doi:S0306-9877(07)00537-3 [pii] 10.1016/j.mehy.2007.08.016
Cappiello A, Malison RT, McDougle CJ, Vegso SJ, Charney DS, Heninger GR, Price LH (1996) Seasonal variation in neuroendocrine and mood responses to i.v. L-tryptophan in depressed patients and healthy subjects. Neuropsychopharmacology 15(5):475–483. doi:S0893-133X(96)00057-7 [pii] 10.1016/S0893-133X(96)00057-7
Chakrabarti S, Fombonne E (2005) Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 162(6):1133–1141. doi:162/6/1133 [pii] 10.1176/appi.ajp.162.6.1133
Chess S (1971) Autism in children with congenital rubella. J Autism Child Schizophr 1(1):33–47
Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M (2007) Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 36(6):361–365. doi:S0887-8994(07)00062-8 [pii] 10.1016/j.pediatrneurol.2007.01.012
Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani HT (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45(3):287–295
Ciaranello AL, Ciaranello RD (1995) The neurobiology of infantile autism. Annu Rev Neurosci 18:101–128. doi:10.1146/annurev.ne.18.030195.000533
Coe CL, Lubach GR (2005) Prenatal origins of individual variation in behavior and immunity. Neurosci Biobehav Rev 29(1):39–49. doi:S0149-7634(04)00149-6 [pii] 10.1016/j.neubiorev.2004.11.003
Cohly HH, Panja A (2005) Immunological findings in autism. Int Rev Neurobiol 71:317–341
Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN (1999) Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14(6):388–394
Correll PH, Morrison AC, Lutz MA (2004) Receptor tyrosine kinases and the regulation of macrophage activation. J Leukoc Biol 75(5):731–737. doi:10.1189/jlb.0703347jlb.0703347 [pii]
Coury DL, Ashwood P, Fasano A, Fuchs G, Geraghty M, Kaul A, Mawe G, Patterson P, Jones NE (2012) Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics 130(Suppl 2):S160–168. doi:10.1542/peds.2012-0900N
Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C, Marques C, Ataide A, Miguel TS, Moore JH, Oliveira G, Vicente AM (2007) Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 121(2):243–256. doi:10.1007/s00439-006-0301-3
D’Amelio M, Ricci I, Sacco R, Liu X, D’Agruma L, Muscarella LA, Guarnieri V, Militerni R, Bravaccio C, Elia M, Schneider C, Melmed R, Trillo S, Pascucci T, Puglisi-Allegra S, Reichelt KL, Macciardi F, Holden JJ, Persico AM (2005) Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry 10(11):1006–1016. doi:10.1038/sj.mp.4001714
D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E, Giardini O (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr 85(9):1076–1079
Dalakas MC (1997) Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 126(9):721–730
Daniels WW, Warren RP, Odell JD, Maciulis A, Burger RA, Warren WL, Torres AR (1995) Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology 32(3):120–123
de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51(4):418–424. doi:10.1097/MPG.0b013e3181dcc4a5
de Theije CG, Wu J, da Silva SL, Kamphuis PJ, Garssen J, Korte SM, Kraneveld AD (2011) Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. Eur J Pharmacol 668(Suppl 1):S70–80. doi:10.1016/j.ejphar.2011.07.013
DeLong GR, Bean SC, Brown FR 3rd (1981) Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 38(3):191–194
Depino AM (2006) Maternal infection and the offspring brain. J Neurosci 26(30):7777–7778
Depino AM (2013) Peripheral and central inflammation in autism spectrum disorders. Mol Cell Neurosci 53:69–76. doi:S1044-7431(12)00185-6 [pii] 10.1016/j.mcn.2012.10.003
Depino AM, Alonso M, Ferrari C, del Rey A, Anthony D, Besedovsky H, Medina JH, Pitossi F (2004) Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation. Hippocampus 14(4):526–535
Depino AM, Lucchina L, Pitossi F (2011) Early and adult hippocampal TGF-beta1 overexpression have opposite effects on behavior. Brain Behav Immun 25(8):1582–1591. doi:S0889-1591(11)00180-2 [pii] 10.1016/j.bbi.2011.05.007
Deverman BE, Patterson PH (2009) Cytokines and CNS development. Neuron 64(1):61–78. doi:S0896-6273(09)00680-1 [pii] 10.1016/j.neuron.2009.09.002
Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8(5):337–348. doi:nri2295 [pii] 10.1038/nri2295
Emanuele E, Orsi P, Boso M, Broglia D, Brondino N, Barale F, di Nemi SU, Politi P (2010) Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471(3):162–165. doi:S0304-3940(10)00061-3 [pii] 10.1016/j.neulet.2010.01.033
Engstrom H, Ohlson S, Stubbs EG, Maciulis A, Caldwell V, Odell JD, Torres A (2003) Decreased expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from participants with autism. J Develop Phys Disabil 15(2):155–163. doi:10.1023/A:1022827417414
Enstrom AM, Onore CE, de Water JAV, Ashwood P (2010a) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24(1):64–71. doi:10.1016/j.bbi.2009.08.001
Enstrom AM, Onore CE, Van de Water JA, Ashwood P (2010b) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24(1):64–71. doi:S0889-1591(09)00388-2 [pii] 10.1016/j.bbi.2009.08.001
Erickson MA, Dohi K, Banks WA (2012) Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation 19(2):121–130. doi:000330247 [pii] 10.1159/000330247
Fatemi SH, Stary JM, Halt AR, Realmuto GR (2001) Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 31(6):529–535
Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52(8):805–810
Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD (2009a) Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 8(1):64–69. doi:10.1007/s12311-008-0075-3
Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD (2009b) GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 39(2):223–230. doi:10.1007/s10803-008-0646-7
Finegold SM (2011) State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe 17(6):367–368. doi:10.1016/j.anaerobe.2011.03.007
Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A (2002) Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35(Suppl 1):S6–S16. doi:10.1086/341914
Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA 3rd (2010) Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16(4):444–453. doi:10.1016/j.anaerobe.2010.06.008
Finegold SM, Downes J, Summanen PH (2012) Microbiology of regressive autism. Anaerobe 18(2):260–262. doi:10.1016/j.anaerobe.2011.12.018
Fombonne E (2005) Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry 66(Suppl 10):3–8
Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, Walker-Smith JA, Murch SH (2001) Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 138(3):366–372. doi:S0022-3476(01)92227-9 [pii] 10.1067/mpd.2001.111323
Garay PA, Hsiao EY, Patterson PH, McAllister AK (2012) Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun. doi:S0889-1591(12)00191-2 [pii] 10.1016/j.bbi.2012.07.008
Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30(3):303–311. doi:S0969-9961(08)00024-7 [pii] 10.1016/j.nbd.2008.01.012
Geier MR, Geier DA (2005) The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med Hypotheses 64(5):946–954. doi:S0306-9877(04)00615-2 [pii] 10.1016/j.mehy.2004.11.018
Ghaziuddin M, Tsai LY, Eilers L, Ghaziuddin N (1992) Brief report: autism and herpes simplex encephalitis. J Autism Dev Disord 22(1):107–113
Gillberg C (1986) Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. J Autism Dev Disord 16(3):369–375
Golnik AE, Ireland M (2009) Complementary alternative medicine for children with autism: a physician survey. J Autism Dev Disord 39(7):996–1005. doi:10.1007/s10803-009-0714-7
Greer MK, Lyons-Crews M, Mauldin LB, Brown FR 3rd (1989) A case study of the cognitive and behavioral deficits of temporal lobe damage in herpes simplex encephalitis. J Autism Dev Disord 19(2):317–326
Gregg JP, Lit L, Baron CA, Hertz-Picciotto I, Walker W, Davis RA, Croen LA, Ozonoff S, Hansen R, Pessah IN, Sharp FR (2008) Gene expression changes in children with autism. Genomics 91(1):22–29. doi:S0888-7543(07)00232-7 [pii] 10.1016/j.ygeno.2007.09.003
Grigorenko EL, Han SS, Yrigollen CM, Leng L, Mizue Y, Anderson GM, Mulder EJ, de Bildt A, Minderaa RB, Volkmar FR, Chang JT, Bucala R (2008) Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 122(2):e438–445. doi:122/2/e438 [pii] 10.1542/peds.2007-3604
Gupta S (1999) Treatment of children with autism with intravenous immunoglobulin. J Child Neurol 14(3):203–205
Gupta S, Aggarwal S, Rashanravan B, Lee T (1998) Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 85(1):106–109. doi:S0165-5728(98)00021-6 [pii]
Hanley HG, Stahl SM, Freedman DX (1977) Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry 34(5):521–531
Harrington LE, Mangan PR, Weaver CT (2006) Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18(3):349–356. doi:S0952-7915(06)00065-3 [pii] 10.1016/j.coi.2006.03.017
Herman GE, Butter E, Enrile B, Pastore M, Prior TW, Sommer A (2007) Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly. Am J Med Genet A 143(6):589–593. doi:10.1002/ajmg.a.31619
Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN (2006) The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114(7):1119–1125
Hoeffer CA, Klann E (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33(2):67–75. doi:10.1016/j.tins.2009.11.003
Hoekstra RA, Wheelwright S (2009) Autistic traits in simplex and multiplex autism families: focus on unaffected relatives. Am J Med Genet B Neuropsychiatr Genet. doi:10.1002/ajmg.b.30947
Hoekstra PJ, Troost PW, Lahuis BE, Mulder H, Mulder EJ, Franke B, Buitelaar JK, Anderson GM, Scahill L, Minderaa RB (2010) Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2 C receptor gene. J Child Adolesc Psychopharmacol 20(6):473–477. doi:10.1089/cap.2009.0071
Holt R, Barnby G, Maestrini E, Bacchelli E, Brocklebank D, Sousa I, Mulder EJ, Kantojarvi K, Jarvela I, Klauck SM, Poustka F, Bailey AJ, Monaco AP (2010) Linkage and candidate gene studies of autism spectrum disorders in European populations. Eur J Hum Genet 18(9):1013–1019. doi:ejhg201069 [pii] 10.1038/ejhg.2010.69
Horvath K, Perman JA (2002) Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 4(3):251–258
Hoyler T, Klose CS, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, Voehringer D, Busslinger M, Diefenbach A (2012) The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37(4):634–648. doi:10.1016/j.immuni.2012.06.020
Ivarsson SA, Bjerre I, Vegfors P, Ahlfors K (1990) Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 21(2):102–103. doi:10.1055/s-2008-1071471
Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B (2005) Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51(2):77–85. doi:84164 [pii] 10.1159/000084164
Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H (2008) Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation 5:52. doi:1742-2094-5-52 [pii] 10.1186/1742-2094-5-52
Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS ONE 8(7):e68322. doi:10.1371/journal.pone.0068322
Kersse K, Vanden Berghe T, Lamkanfi M, Vandenabeele P (2007) A phylogenetic and functional overview of inflammatory caspases and caspase-1-related CARD-only proteins. Biochem Soc Trans 35(Pt 6):1508–1511. doi:BST0351508 [pii] 10.1042/BST0351508
Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25(3):154–159. doi:S0166223600020889 [pii]
Lam KS, Aman MG, Arnold LE (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27(3):254–289. doi:10.1016/j.ridd.2005.03.003
Lamkanfi M, Kanneganti TD, Franchi L, Nunez G (2007) Caspase-1 inflammasomes in infection and inflammation. J Leukoc Biol 82(2):220–225. doi:jlb.1206756 [pii] 10.1189/jlb.1206756
Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E (2002) Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125(Pt 7):1483–1495
Lee LC, Zachary AA, Leffell MS, Newschaffer CJ, Matteson KJ, Tyler JD, Zimmerman AW (2006) HLA-DR4 in families with autism. Pediatr Neurol 35(5):303–307. doi:S0887-8994(06)00383-3 [pii] 10.1016/j.pediatrneurol.2006.06.006
Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137–161. doi:10.1146/annurev.immunol.16.1.137
Levy SE, Mandell DS, Merhar S, Ittenbach RF, Pinto-Martin JA (2003) Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr 24(6):418–423
Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M (2009) Elevated immune response in the brain of autistic patients. J Neuroimmunol 207(1–2):111–116. doi:S0165-5728(08)00490-6 [pii] 10.1016/j.jneuroim.2008.12.002
Lintas C, Sacco R, Garbett K, Mirnics K, Militerni R, Bravaccio C, Curatolo P, Manzi B, Schneider C, Melmed R, Elia M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM (2009) Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Mol Psychiatry 14(7):705–718. doi:mp200821 [pii] 10.1038/mp.2008.21
Liu G, Yang K, Burns S, Shrestha S, Chi H (2010) The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat Immunol 11(11):1047–1056. doi:ni.1939 [pii] 10.1038/ni.1939
Lucchina L, Depino AM (2014) Altered peripheral and central inflammatory responses in a mouse model of autism. Autism Res 7(2):273–289. doi:10.1002/aur.1338
MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP (2011) Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder. Behav Brain Res 217(1):47–54. doi:S0166-4328(10)00677-7 [pii] 10.1016/j.bbr.2010.10.005
Madsen-Bouterse SA, Romero R, Tarca AL, Kusanovic JP, Espinoza J, Kim CJ, Kim JS, Edwin SS, Gomez R, Draghici S (2010) The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol 63(1):73–92. doi:AJI791 [pii] 10.1111/j.1600-0897.2009.00791.x
Malik M, Sheikh AM, Wen G, Spivack W, Brown WT, Li X (2011) Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 216(1–2):80–85. doi:S0171-2985(10)00024-0 [pii] 10.1016/j.imbio.2010.03.001
Maloy KJ (2008) The Interleukin-23/Interleukin-17 axis in intestinal inflammation. J Intern Med 263(6):584–590. doi:10.1111/j.1365-2796.2008.01950.x
Markowitz PI (1983) Autism in a child with congenital cytomegalovirus infection. J Autism Dev Disord 13(3):249–253
Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK (2004) Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 123(1–2):81–90. doi:10.1016/j.molbrainres.2004.01.003S0169328X0400035X [pii]
Matarazzo EB (2002) Treatment of late onset autism as a consequence of probable autommune processes related to chronic bacterial infection. World J Biol Psychiatry 3(3):162–166
McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53(11):993–1000
McLay RN, Kastin AJ, Zadina JE (2000) Passage of interleukin-1-beta across the blood-brain barrier is reduced in aged mice: a possible mechanism for diminished fever in aging. Neuroimmunomodulation 8(3):148–153. doi:54275 [pii] 54275
Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343(5):338–344. doi:10.1056/NEJM200008033430506
Merali Z, Lacosta S, Anisman H (1997) Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res 761(2):225–235. doi:S0006-8993(97)00312-0 [pii]
Merrill JE (1992) Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14(1):1–10
Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J (2006) The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26(18):4752–4762
Meyer U, Yee BK, Feldon J (2007) The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist 13(3):241–256. doi:13/3/241 [pii] 10.1177/1073858406296401
Meyer U, Feldon J, Yee BK (2009) A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35(5):959–972. doi:sbn022 [pii] 10.1093/schbul/sbn022
Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1987) Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biol Psychiatry 22(8):933–940
Mjosberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, te Velde AA, Fokkens WJ, van Drunen CM, Spits H (2012) The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37(4):649–659. doi:10.1016/j.immuni.2012.08.015
Mohankumar PS, Thyagarajan S, Quadri SK (1991) Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci 48(9):925–930
Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, Wills-Karp M (2006) Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172(1–2):198–205. doi:S0165-5728(05)00492-3 [pii] 10.1016/j.jneuroim.2005.11.007
Mondino A, Mueller DL (2007) mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol 19(3):162–172. doi:10.1016/j.smim.2007.02.008
Mostafa GA, Al Shehab A, Fouad NR (2010) Frequency of CD4+ CD25high regulatory T cells in the peripheral blood of Egyptian children with autism. J Child Neurol 25(3):328–335. doi:10.1177/0883073809339393
Niehus R, Lord C (2006) Early medical history of children with autism spectrum disorders. J Dev Behav Pediatr 27(2 Suppl):S120–127
Nijmeijer JS, Arias-Vasquez A, Rommelse NN, Altink ME, Anney RJ, Asherson P, Banaschewski T, Buschgens CJ, Fliers EA, Gill M, Minderaa RB, Poustka L, Sergeant JA, Buitelaar JK, Franke B, Ebstein RP, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sonuga-Barke EJ, Steinhausen HC, Faraone SV, Hartman CA, Hoekstra PJ (2010) Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach. J Am Acad Child Adolesc Psychiatry 49(7):675–685. doi:10.1016/j.jaac.2010.03.015
Okada K, Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, Suda S, Suzuki K, Sugihara G, Matsuzaki H, Sugiyama T, Kawai M, Minabe Y, Takei N, Mori N (2007) Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 31(1):187–190. doi:S0278-5846(06)00339-3 [pii] 10.1016/j.pnpbp.2006.08.020
Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, Blumberg RS (2012) Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336(6080):489–493. doi:10.1126/science.1219328
Onore C, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen R, Van de Water J, Ashwood P (2009) Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol 216(1–2):126–129. doi:10.1016/j.jneuroim.2009.09.005
Owens DF, Kriegstein AR (2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3(9):715–727
Pardo CA, Eberhart CG (2007) The neurobiology of autism. Brain Pathol 17(4):434–447
Pardo CA, Vargas DL, Zimmerman AW (2005) Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry (Abingdon, England) 17(6):485–495
Parracho HM, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54(Pt 10):987–991. doi:54/10/987 [pii] 10.1099/jmm.0.46101-0
Plioplys AV (1998) Intravenous immunoglobulin treatment of children with autism. J Child Neurol 13(2):79–82
Pradhan S, Gupta RP, Shashank S, Pandey N (1999) Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 165(1):56–61. doi:S0022-510X(99)00072-6 [pii]
Prat A, Biernacki K, Wosik K, Antel JP (2001) Glial cell influence on the human blood-brain barrier. Glia 36(2):145–155. doi:10.1002/glia.1104 [pii]
Ray MA, Graham AJ, Lee M, Perry RH, Court JA, Perry EK (2005) Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus. Neurobiol Dis 19(3):366–377. doi:10.1016/j.nbd.2005.01.017
Ring A, Barak Y, Ticher A, Ashkenazi I, Elizur A, Weizman A (1997) Evidence for an infectious etiology in autism. Pathophysiology 4:91–96
Rodriguez-Escudero I, Oliver MD, Andres-Pons A, Molina M, Cid VJ, Pulido R (2011) A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. Hum Mol Genet 20(21):4132–4142. doi:10.1093/hmg/ddr337
Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H (1993) Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 87(5):312–316
Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85(1):9–18; quiz 18, 21. doi:S1081-1206(10)62426-X [pii] 10.1016/S1081-1206(10)62426-X
Romagnani P, Annunziato F, Piccinni MP, Maggi E, Romagnani S (2000) Th1/Th2 cells, their associated molecules and role in pathophysiology. Eur Cytokine Netw 11(3):510–511
Romero R, Gotsch F, Pineles B, Kusanovic JP (2007) Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 65(12 Pt 2):S194–202
Rosen NJ, Yoshida CK, Croen LA (2007) Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 119(1):e61–69. doi:119/1/e61 [pii] 10.1542/peds.2006-1788
Round JL, O'Connell RM, Mazmanian SK (2010) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34(3):J220–225. doi:10.1016/j.jaut.2009.11.007
Rout UK, Clausen P (2009) Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders. Neurosci Res 64(2):162–169. doi:S0168-0102(09)00063-7 [pii] 10.1016/j.neures.2009.02.009
Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML, Nelson MN, Wexler HM (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15(7):429–435
Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O’Connor E, Shokat KM, Fisher AG, Merkenschlager M (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105(22):7797–7802. doi:10.1073/pnas.0800928105
Schain RJ, Freedman DX (1961) Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 58:315–320
Schmitz C, van Kooten IA, Hof PR, van Engeland H, Patterson PH, Steinbusch HW (2005) Autism: neuropathology, alterations of the GABAergic system, and animal models. Int Rev Neurobiol 71:1–26
Shenoy S, Arnold S, Chatila T (2000) Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome. J Pediatr 136(5):682–687. doi:S0022-3476(00)48959-6 [pii] 10.1067/mpd.2000.105355
Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M (1993) Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 13(8):3574–3581
Singh VK (1996) Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 66(1–2):143–145
Singh VK, Jensen RL (2003) Elevated levels of measles antibodies in children with autism. Pediatr Neurol 28(4):292–294. doi:S0887899402006276 [pii]
Siniscalco D, Antonucci N (2013) Involvement of dietary bioactive proteins and peptides in autism spectrum disorders. Curr Protein Pept Sci 14(8):674–679
Siniscalco D, Sapone A, Giordano C, Cirillo A, de Novellis V, de Magistris L, Rossi F, Fasano A, Maione S, Antonucci N (2012) The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients. J Autism Dev Disord 42(7):1403–1410. doi:10.1007/s10803-011-1373-z
Snijders TM, Milivojevic B, Kemner C (2013) Atypical excitation-inhibition balance in autism captured by the gamma response to contextual modulation. Neuroimage Clin 3:65–72. doi:10.1016/j.nicl.2013.06.015
Sousa I, Clark TG, Holt R, Pagnamenta AT, Mulder EJ, Minderaa RB, Bailey AJ, Battaglia A, Klauck SM, Poustka F, Monaco AP (2010) Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry. Mol Autism 1(1):7. doi:2040-2392-1-7 [pii] 10.1186/2040-2392-1-7
Stubbs EG (1978) Autistic symptoms in a child with congenital cytomegalovirus infection. J Autism Child Schizophr 8(1):37–43
Stubbs EG, Ash E, Williams CP (1984) Autism and congenital cytomegalovirus. J Autism Dev Disord 14(2):183–189
Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204(8):1775–1785. doi:jem.20070602 [pii] 10.1084/jem.20070602
Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N (2011) Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 6(5):e20470. doi:10.1371/journal.pone.0020470 PONE-D-11-06135 [pii]
Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies SE, Wakefield AJ, Thomson MA, Walker-Smith JA, Murch SH (2002) Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7(4):375–382, 334. doi:10.1038/sj.mp.4001077
Torres AR, Sweeten TL, Cutler A, Bedke BJ, Fillmore M, Stubbs EG, Odell D (2006) The association and linkage of the HLA-A2 class I allele with autism. Hum Immunol 67(4–5):346–351. doi:S0198-8859(06)00042-5 [pii] 10.1016/j.humimm.2006.01.001
Ueda A, Zhou L, Stein PL (2012) Fyn promotes Th17 differentiation by regulating the kinetics of RORgammat and Foxp3 expression. J Immunol 188(11):5247–5256. doi:jimmunol.1102241 [pii] 10.4049/jimmunol.1102241
van Doorninck JH, van Der Wees J, Karis A, Goedknegt E, Engel JD, Coesmans M, Rutteman M, Grosveld F, De Zeeuw CI (1999) GATA-3 is involved in the development of serotonergic neurons in the caudal raphe nuclei. J Neurosci 19(12):RC12
van Gent T, Heijnen CJ, Treffers PD (1997) Autism and the immune system. J Child Psychol Psychiatry 38(3):337–349
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57(1):67–81
Vojdani A, Pangborn JB, Vojdani E, Cooper EL (2003) Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol 16(3):189–199
Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, O’Leary JJ, Berelowitz M, Walker-Smith JA (2000) Enterocolitis in children with developmental disorders. Am J Gastroenterol 95(9):2285–2295. doi:S0002-9270(00)02041-4 [pii] 10.1111/j.1572-0241.2000.03248.x
Wallach D, Kang TB, Rajput A, Kim JC, Bogdanov K, Yang SH, Kovalenko A (2010) Anti-inflammatory functions of the “apoptotic” caspases. Ann N Y Acad Sci 1209:17–22. doi:10.1111/j.1749-6632.2010.05742.x
Warren RP, Margaretten NC, Pace NC, Foster A (1986) Immune abnormalities in patients with autism. J Autism Dev Disord 16(2):189–197
Warren RP, Yonk J, Burger RW, Odell D, Warren WL (1995) DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology 31(2):53–57
Wong HH, Smith RG (2006) Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. J Autism Dev Disord 36(7):901–909. doi:10.1007/s10803-006-0131-0
Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T (2003) Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord 33(4):455–459
Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, Olivier M, Piccirillo CA (2012) Inflammation-driven reprogramming of CD4+ Foxp3 + regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS ONE 7(4):e35572. doi:10.1371/journal.pone.0035572 PONE-D-11-25382 [pii]
Acknowledgments
This work was supported by Autism Biomarkers Project of CIREN (M.A.R-A.), Havana University (M.C.I.J.), a CONICET Grant PIP 2012, a University of Buenos Aires Grant UBACyT GEF2013-2015, and an ANPCyT Grant PICT2010 (A.M.D.). A.M.D. is a member of the Research Career at the National Council of Scientific and Technological Research (CONICET).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Depino, A., Robinson-Agramonte, M. (2015). Understanding on Neuroimmunology in Autism Spectrum Disorder. In: Robinson-Agramonte, M. (eds) Translational Approaches to Autism Spectrum Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-16321-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-16321-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16320-8
Online ISBN: 978-3-319-16321-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)